Moxetumomab pasudotox-tdfk Intravenous and Vivitrol
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Vivitrol and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: naltrexone
Brand name: Vivitrol, Depade, ReVia
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-VIViva CT Prenatal
- Moxetumomab pasudotox-tdfk Intravenous-Vivlodex
- Moxetumomab pasudotox-tdfk Intravenous-Vivotif
- Moxetumomab pasudotox-tdfk Intravenous-Vivotif Berna
- Moxetumomab pasudotox-tdfk Intravenous-Vizimpro
- Moxetumomab pasudotox-tdfk Intravenous-Vofenal
- Vivitrol-Moxifloxacin
- Vivitrol-Moxifloxacin (Systemic)
- Vivitrol-Moxifloxacin Hydrochloride
- Vivitrol-Moxifloxacin Injection
- Vivitrol-Moxifloxacin Intravenous
- Vivitrol-Moxifloxacin Tablets